Cliff Asness's GILD Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 2.38 M shares of Gilead Sciences, Inc. (GILD) worth $264.13 M, representing 0.17% of the portfolio. First purchased in 2012-Q4, this long-term strategic position has been held for 52 quarters.
Based on 13F filings since 2013, Cliff Asness has maintained a long-term strategic position in GILD, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2017, adding 3.52 M shares. Largest reduction occurred in Q2 2019, reducing 3.54 M shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Gilead Sciences (GILD) Holding Value Over Time
Track share changes against reported price movement
Quarterly Gilead Sciences (GILD) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2012 | +190,442 | Add 0.00% | 190,442 | $36.73 |
| Q2 2013 | +613,737 | Add 0.00% | 613,737 | $51.21 |
| Q3 2013 | -143,586 | Reduce 23.40% | 470,151 | $62.84 |
| Q4 2013 | +447,607 | Add 95.20% | 917,758 | $75.15 |
| Q1 2014 | +439,427 | Add 47.88% | 1.36 M | $70.86 |
| Q2 2014 | -388,000 | Reduce 28.59% | 969,185 | $82.91 |
| Q3 2014 | +1.29 M | Add 133.34% | 2.26 M | $106.45 |
| Q4 2014 | +2.57 M | Add 113.64% | 4.83 M | $94.26 |
| Q1 2015 | -716,746 | Reduce 14.84% | 4.11 M | $98.13 |
| Q2 2015 | +67,030 | Add 1.63% | 4.18 M | $117.08 |
| Q3 2015 | +586,783 | Add 14.03% | 4.77 M | $98.19 |
| Q4 2015 | -800,138 | Reduce 16.78% | 3.97 M | $101.19 |
| Q1 2016 | -977,184 | Reduce 24.62% | 2.99 M | $91.86 |
| Q2 2016 | -140,407 | Reduce 4.69% | 2.85 M | $83.42 |
| Q3 2016 | +1.31 M | Add 45.96% | 4.16 M | $79.12 |
| Q4 2016 | -13,985 | Reduce 0.34% | 4.15 M | $71.61 |
| Q1 2017 | +1.07 M | Add 25.71% | 5.21 M | $67.92 |
| Q2 2017 | +3.52 M | Add 67.50% | 8.73 M | $70.78 |
| Q3 2017 | +3.38 M | Add 38.76% | 12.12 M | $81.02 |
| Q4 2017 | +516,486 | Add 4.26% | 12.63 M | $71.64 |
| Q1 2018 | -1.98 M | Reduce 15.66% | 10.65 M | $75.39 |
| Q2 2018 | -1.76 M | Reduce 16.56% | 8.89 M | $70.84 |
| Q3 2018 | -545,884 | Reduce 6.14% | 8.34 M | $77.21 |
| Q4 2018 | +326,298 | Add 3.91% | 8.67 M | $62.55 |
| Q1 2019 | +285,954 | Add 3.30% | 8.96 M | $65.01 |
| Q2 2019 | -3.54 M | Reduce 39.50% | 5.42 M | $67.02 |
| Q3 2019 | -891,623 | Reduce 16.46% | 4.53 M | $63.30 |
| Q4 2019 | +2.68 M | Add 59.25% | 7.21 M | $64.44 |
| Q1 2020 | -1.41 M | Reduce 19.58% | 5.8 M | $74.76 |
| Q2 2020 | -1.14 M | Reduce 19.60% | 4.66 M | $75.68 |
| Q3 2020 | -903,477 | Reduce 19.38% | 3.76 M | $62.49 |
| Q4 2020 | -786,288 | Reduce 20.93% | 2.97 M | $56.97 |
| Q1 2021 | -1 M | Reduce 33.67% | 1.97 M | $64.63 |
| Q2 2021 | -814,483 | Reduce 41.33% | 1.16 M | $68.31 |
| Q3 2021 | -18,824 | Reduce 1.63% | 1.14 M | $69.85 |
| Q4 2021 | +92,279 | Add 8.11% | 1.23 M | $72.61 |
| Q1 2022 | +1.48 M | Add 120.51% | 2.71 M | $59.45 |
| Q2 2022 | +3.38 M | Add 124.77% | 6.1 M | $61.61 |
| Q3 2022 | -582,541 | Reduce 9.56% | 5.51 M | $61.69 |
| Q4 2022 | -1.74 M | Reduce 31.62% | 3.77 M | $85.35 |
| Q1 2023 | -259,147 | Reduce 6.87% | 3.51 M | $81.78 |
| Q2 2023 | +731,362 | Add 20.83% | 4.24 M | $76.53 |
| Q3 2023 | +531,314 | Add 12.52% | 4.77 M | $74.94 |
| Q4 2023 | -909,512 | Reduce 19.05% | 3.86 M | $80.92 |
| Q1 2024 | -549,472 | Reduce 14.22% | 3.31 M | $73.25 |
| Q2 2024 | -1.26 M | Reduce 38.06% | 2.05 M | $68.61 |
| Q3 2024 | -110,001 | Reduce 5.36% | 1.94 M | $83.70 |
| Q4 2024 | -129,518 | Reduce 6.67% | 1.81 M | $92.37 |
| Q1 2025 | +51,116 | Add 2.82% | 1.86 M | $111.21 |
| Q2 2025 | +606,168 | Add 32.51% | 2.47 M | $110.17 |
| Q3 2025 | -91,292 | Reduce 3.69% | 2.38 M | $111.00 |
Cliff Asness's Gilead Sciences Investment FAQs
Cliff Asness first purchased Gilead Sciences, Inc. (GILD) in Q4 2012, acquiring 190,442 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Gilead Sciences, Inc. (GILD) for 52 quarters since Q4 2012.
Cliff Asness's largest addition to Gilead Sciences, Inc. (GILD) was in Q2 2017, adding 8,731,680 shares worth $618.03 M.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 2,379,546 shares of Gilead Sciences, Inc. (GILD), valued at approximately $264.13 M.
As of the Q3 2025 filing, Gilead Sciences, Inc. (GILD) represents approximately 0.17% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Gilead Sciences, Inc. (GILD) was 12,632,789 shares, as reported at the end of Q4 2017.